Beyond the device: From producer to problem solver

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

In the New Health Economy, medical device and diagnostics manufacturers are making new connections with health systems, healthcare providers, pharmaceutical companies and others to lower costs and improve the lives of patients.

The medical device industry is uniquely positioned to solve some of healthcare’s most intractable problems. Learn how device and diagnostics manufacturers are making new connections with health systems, healthcare providers, pharmaceutical companies and others to lower costs and improve the lives of patients in the New Health Economy.

The medical device industry is uniquely positioned to solve some of healthcare’s most intractable problems. Learn how device and diagnostics manufacturers are making new connections with health systems, healthcare providers, pharmaceutical companies and others to lower costs and improve the lives of patients in the New Health Economy.

  • Medical device manufacturers are launching broad service offerings attuned to customer needs.
  • Medtech companies are leveraging the cloud to improve clinical workflow.
  • Physicians are looking to remote monitoring and real-time data and analytics solutions to improve patient outcomes.
  • Across device segments, manufacturers are incorporating clinician and consumer perspectives into solution design.

Medical device and diagnostic companies now offer services that engage patients in real-time, improve physician performance, and demonstrate value beyond any one device, diagnostic or technology.
 
To understand how the medical device and technology industry is changing its business model in key segments – including diagnostics, imaging and implants – HRI interviewed top executives at large medtech firms and analyzed recent organizational changes among the top 10 medical device companies by revenue. HRI also interviewed CEOs representing some of the industry’s new entrants to understand how these organizations are competing in the New Health Economy.

Contact us

Michael Swanick

Global Pharmaceutical and Life Sciences Leader, PwC US

Tel: +1 (267) 330 6060

Douglas Strang

Global Pharmaceutical and Life Sciences Advisory Leader, PwC US

Tel: +1 (267) 330 3045

Benjamin Isgur

Health Research Institute Leader, PwC US

Trine K. Tsouderos

HRI Regulatory Center Leader, PwC US

Follow us